Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer
Early-stage CRC patients can have distinct genomic profiles and CGP in this population can help expand access to targeted therapies.
Authors
- Aparna R. Parikh (ORCID: https://orcid.org/0000-0002-5245-7841)
- Richard S.P. Huang (ORCID: https://orcid.org/0000-0001-8395-5168)
- Júlia C.F. Quintanilha (ORCID: https://orcid.org/0000-0001-6908-4474)
- Leontios Pappas (ORCID: https://orcid.org/0000-0003-2276-8398)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
- Foundation Medicine (United States)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1093/oncolo/oyae269
- Citations
- 1
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Flatiron Health
- Foundation Medicine